Skip to main content

Celularity Inc

corporate_fare Company Profile

Celularity Inc

CELU·NASDAQ·Life Sciences·CIK 0001752828

Celularity Inc is a cellular and regenerative medicine company focused on advancing health longevity and redefining the standard of care for age-related disease using novel therapies derived from the post-partum human placenta. The company's objective of extending health longevity is to meaningfully reduce the duration and severity in which an individual experiences aging-related degenerative diseases and disorders associated with increased mortality towards the end of life. Aging is a major risk factor for many degenerative disorders and diseases across multiple high-value therapeutic areas, including immunology and regenerative medicine. Common to all degenerative disorders and diseases is the progressive loss of function or structure (or both) of affected tissues and organs driven by underlying cellular dysfunction, which directly impacts regenerative capacity, healthspan and overall lifespan. Age-associated immunosenescence and other physiological changes contribute to increased vulnerability to infections, which further exacerbate aging-related decline and are increasingly associated with frailty and adverse clinical outcomes. Aging and longevity are determined by a complex combination of genetic, nongenetic, and environmental factors. While aging is not itself a disease, it increases vulnerability to disease and is among the most important known risk factors for most chronic diseases; for example, aging is a primary driver of cancer and other chronic conditions. The accumulation of senescent cells in aged tissues is suggested to be a key factor underlying age-related cancer, and age is a key risk factor for autoimmune disease, with many autoimmune diseases preferentially occurring in the second half of adulthood as immune function declines. These processes are increasingly linked to age-related immune dysregulation. Aging is associated with a progressive degeneration of tissues, resulting in significant impairment on the structure and function of vital organs. Chronic, low-grade systemic inflammation, often referred to as "inflammaging," is characterized by higher levels of circulating pro-inflammatory cytokines driven by cellular damage and senescent cell accumulation. Senescent cells contribute to disease progression by limiting the regenerative capacity of tissue stem cells and inducing the accumulation of cellular damage.

Celularity Inc (NASDAQ:CELU) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 29 items for CELU at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-10, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for CELU spans DEF 14A, PRE 14A, 10-Q, SCHEDULE 13D/A.

Recent high-impact activity:

  • Celularity Sets Dec 30 Vote on Nasdaq Share Issuance, With 10% Price Cut if Rejected
  • Celularity Seeks Nasdaq Approval for Convertible Note Shares; 10% Price Cut if Vote Fails
  • Celularity Q2 10-Q: Going Concern Reaffirmed, $0.6M Cash, Nasdaq Filing Deficiency
  • Celularity Revenue Plunges 66% as Going-Concern Doubts Mount
  • Celularity's Late 10-Q Reveals Going Concern Warning, $368K Cash, and Material Weaknesses

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$26.55M
Net Income
-$91.72M
Diluted EPS
-$3.59
Op. Cash Flow
-$13.25M
Gross Profit
$6.48M
Operating Income
-$61.31M
Cash & Equivalents
$6.17M
Debt / Equity
0.00×
Net Margin
-345.4%
Shares Outstanding
28.84M sh
Source: 10-K · filed 2026-04-30 · accession 0001493152-26-020424

Short Interest & Short Volume

2.33 days to cover

FINRA reported short interest of 534,811 shares in CELU as of the October 30, 2026 settlement, a 21.1% increase from the prior period — about 2.3 days to cover at its recent average daily volume. On November 20, 2026, 60.0% of CELU volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)534,811 shares as of October 30, 2026
Change vs prior period▲ 21.1%
Days to cover2.33 at avg daily volume of 229,894
Daily short volume (FINRA facilities)60.0% of 222,724 shares on November 20, 2026
5-day average short volume45.6%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for CELU, detected from its recent SEC filings · based on capital-structure filings through 2026-09-25.

Director Buys $3.21M Convertible Notes · Warrants and Option for More Notes

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with C →
$0.451 -2.59% today
52-week range · as of 2026-11-10 $0.451 – $2.55
Market cap
$15.02M
Volume
295.9K (1.7× avg)
3-mo avg 174.5K
Live data · 2026-11-22 04:04 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CELU - Latest Insights

CELU
Nov 10, 2026, 4:30 PM EST
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $0.720
Real-time Price: $0.451 info
Change: -$0.269 (-37%) info
Market Cap: $15.025M info
CELU
Oct 28, 2026, 5:52 PM EDT
Filing Type: PRE 14A
Importance Score:
7
Price at Filing: $0.980
Real-time Price: $0.451 info
Change: -$0.529 (-54%) info
Market Cap: $15.025M info
CELU
Oct 20, 2026, 5:08 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.26
Real-time Price: $0.451 info
Change: -$0.809 (-64%) info
Market Cap: $15.025M info
CELU
Oct 05, 2026, 7:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $1.62
Real-time Price: $0.451 info
Change: -$1.16 (-72%) info
Market Cap: $15.025M info
CELU
Sep 29, 2026, 5:02 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.39
Real-time Price: $0.451 info
Change: -$0.939 (-68%) info
Market Cap: $15.025M info
CELU
Sep 28, 2026, 1:14 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $1.39
Real-time Price: $0.451 info
Change: -$0.939 (-68%) info
Market Cap: $15.025M info
CELU
Sep 28, 2026, 6:14 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.47
Real-time Price: $0.451 info
Change: -$1.02 (-69%) info
Market Cap: $15.025M info
CELU
Sep 25, 2026, 4:57 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $1.38
Real-time Price: $0.451 info
Change: -$0.929 (-67%) info
Market Cap: $15.025M info
CELU
Sep 24, 2026, 9:15 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.13
Real-time Price: $0.451 info
Change: -$0.679 (-60%) info
Market Cap: $15.025M info
CELU
Sep 14, 2026, 9:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.42
Real-time Price: $0.451 info
Change: -$0.969 (-68%) info
Market Cap: $15.025M info
CELU
Aug 27, 2026, 9:00 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $0.8808
Real-time Price: $0.451 info
Change: -$0.4298 (-49%) info
Market Cap: $15.025M info
CELU
Aug 07, 2026, 5:10 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.7007
Real-time Price: $0.451 info
Change: -$0.2497 (-36%) info
Market Cap: $15.025M info
CELU
Jul 29, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.6701
Real-time Price: $0.451 info
Change: -$0.2191 (-33%) info
Market Cap: $15.025M info
CELU
Jun 30, 2026, 9:03 AM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $0.630
Real-time Price: $0.451 info
Change: -$0.179 (-28%) info
Market Cap: $15.025M info
CELU
Jun 30, 2026, 9:00 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.630
Real-time Price: $0.451 info
Change: -$0.179 (-28%) info
Market Cap: $15.025M info
CELU
Jun 25, 2026, 5:27 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.6653
Real-time Price: $0.451 info
Change: -$0.2143 (-32%) info
Market Cap: $15.025M info
CELU
Jun 23, 2026, 6:02 AM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $0.758
Real-time Price: $0.451 info
Change: -$0.307 (-41%) info
Market Cap: $15.025M info
CELU
Jun 12, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.7129
Real-time Price: $0.451 info
Change: -$0.2619 (-37%) info
Market Cap: $15.025M info
CELU
Jun 04, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.02
Real-time Price: $0.451 info
Change: -$0.569 (-56%) info
Market Cap: $15.025M info
CELU
Jun 03, 2026, 5:22 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.05
Real-time Price: $0.451 info
Change: -$0.599 (-57%) info
Market Cap: $15.025M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets